West Pharmaceutical Services Cash Flow Statement (2009-2026) | WST

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	178.70M	169.10M	147.70M	166.60M	183.00M	115.80M	99.80M	134.30M	150.10M	157.60M	133.70M	111.00M	106.80M	132.10M	128.10M	86.40M	126.80M	137.90M	128.20M	135.40M
Depreciation and Depletion (Quarter)	27.70M	28.90M	32.30M	28.70M	29.20M	28.90M	30.10M	30.70M	33.60M	34.80M	34.60M	34.70M	38.00M	39.30M	39.80M	39.10M	40.80M	42.30M	46.40M	44.60M
Share-based Compensation (Quarter)	10.30M	11.40M	10.00M	5.50M	5.50M	6.00M	6.70M	8.50M	7.50M	5.90M	1.40M	5.00M	4.30M	5.10M	4.30M	1.30M	7.40M	8.40M	6.70M	6.60M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	-14.90M	15.90M	2.70M	18.80M			3.60M	-9.40M			102.40M	3.70M	22.90M		-8.00M	0.20M	-0.20M	0.80M	0.30M	-1.00M
Asset Writedowns and Impairment (Quarter)					0.20M	1.40M	4.60M	1.90M	1.50M	3.50M	2.70M	0.60M	0.30M	1.00M	5.40M	0.30M	3.80M	0.30M	7.30M	0.30M
Cash from Restructuring (Quarter)																0.80M				0.90M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	144.40M	190.10M	160.80M	151.20M	173.10M	168.90M	230.80M	138.10M	169.20M	230.10M	239.10M	118.20M	165.00M	180.10M	190.10M	129.40M	177.10M	197.20M	251.10M	89.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	1.10M	1.10M	2.10M	0.90M	0.90M	0.90M	1.00M	0.90M	0.50M	0.90M	1.30M	0.90M	0.90M	0.90M	0.90M	0.90M	0.60M	0.70M	0.60M	0.60M
Depreciation & Amortization (CF) (Quarter)	27.70M	28.90M	32.30M	28.70M	29.20M	28.90M	30.10M	30.70M	33.60M	34.80M	34.60M	34.70M	38.00M	39.30M	39.80M	39.10M	40.80M	42.30M	46.40M	44.60M
Change in Working Capital
Other Working Capital Changes (Quarter)	73.60M	-151.00M	-19.90M	50.20M	48.30M	32.20M	-149.20M	46.80M	25.30M	-24.80M	-26.00M	34.60M	-14.10M	0.10M	-43.20M	-0.10M	4.10M	-2.10M	-110.00M	102.90M
Investing Activities
Capital Expenditures (Quarter)	56.90M	65.30M	76.50M	65.80M	66.10M	57.80M	-156.50M	82.10M	75.40M	95.80M	108.70M	90.60M	100.20M	81.30M	-219.10M	37.50M	-2.10M	2.70M	-0.20M	26.10M
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-55.90M	-65.30M	-77.40M	-68.30M	-66.00M	-59.10M	-94.80M	-82.10M	-82.10M	-95.70M	-108.80M	-90.60M	-101.20M	-82.10M	-104.80M	-71.30M	-75.20M	-63.30M	-76.10M	-42.70M
Financing Activities
Other financing activities (Quarter)				1.10M	0.20M		-0.10M					-0.10M
Cash from Financing Activities (Quarter)	0.30M	-5.80M	-6.20M	-172.70M	-36.20M	-75.20M	-9.50M	-71.00M	-176.80M	-22.30M	-189.50M	-271.00M	-218.30M	-64.40M	-68.90M	-147.00M	-14.90M	-11.50M	-11.70M	-308.70M
Dividend Payments
Dividends Paid - Common (Quarter)	12.60M	12.60M	13.30M	13.40M	13.10M	13.50M	14.10M	14.10M	14.10M	14.00M	14.80M	14.70M	14.60M	14.50M	15.30M	15.20M	15.10M	15.10M	15.80M	15.80M
Additional items
Exchange Rate Effect (Quarter)	3.70M	-7.20M	-2.60M	-5.10M	-20.10M	-24.10M	38.80M	7.00M	-0.30M	-9.80M	14.50M	-8.70M	-1.10M	11.10M	-22.70M	8.50M	18.50M	-3.60M	-0.50M	-8.40M
Change in Cash (Quarter)	92.50M	111.80M	74.60M	-94.90M	50.80M	10.50M	165.30M	-8.00M	-90.00M	102.30M	-44.70M	-252.10M	-155.60M	44.70M	-6.30M	-80.40M	105.50M	118.80M	162.80M	-269.90M
Free Cash Flow (Quarter)	87.50M	124.80M	84.30M	85.40M	107.00M	111.10M	387.30M	56.00M	93.80M	134.30M	130.40M	27.60M	64.80M	98.80M	409.20M	91.90M	179.20M	194.50M	251.30M	63.80M
Net Cash Flow (Quarter)	88.80M	119.00M	77.20M	-89.80M	70.90M	34.60M	126.50M	-15.00M	-89.70M	112.10M	-59.20M	-243.40M	-154.50M	33.60M	16.40M	-88.90M	87.00M	122.40M	163.30M	-261.50M

Research Tools

West Pharmaceutical Services Cash Flow Statement (2009-2026) | WST

Create an account

Sign In

Reset Password